vimarsana.com

Latest Breaking News On - David arkowitz - Page 1 : vimarsana.com

The Escalator: VML Health, Madrigal Pharmaceuticals, CG Life and more

Seres Therapeutics, Inc (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kevin Mannix, Head of Investor Relations. Please go ahead. Kevin Mannix: […]

Seres Therapeutics, Inc (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript

Seres secures first approval of oral microbiome product

Seres, together with partners Nestle Health Science, receive approval for its microbiome therapeutic to prevent recurrence of C. difficile infection.

Oaktree Provides $250MM Term Loan Facility to Seres Therapeutics - News

Seres Therapeutics, a leading microbiome therapeutics company, entered into a new $250 million senior secured debt facility ("Term Loan Facility") provided by funds managed by Oaktree Capital Management. The Company drew the first tranche of $110 million at closing, with three additional tranches available. These additional tranches include $90.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.